Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.8% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.54% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
1601
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.42M | ﹤0.01% |
82,600
+16,800
| +26% | +$500K |
|
|
RCM
1602
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.42M | ﹤0.01% |
217,200
+42,100
| +24% | +$433K |
|
1603
CryoPort
CYRX
$766M
| $2.42M | ﹤0.01% |
80,000
+10,500
| +15% | +$234K |
|
|
FBC
1604
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $2.42M | ﹤0.01% |
82,200
+11,000
| +15% | +$282K |
|
|
INVX
1605
Innovex International
INVX
$2.15B
| $2.41M | ﹤0.01% |
80,800
+10,600
| +15% | +$326K |
|
|
MAXR
1606
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.4M | ﹤0.01% |
133,700
+18,100
| +16% | +$234K |
|
1607
Repay Holdings
RPAY
$311M
| $2.4M | ﹤0.01% |
97,283
+36,083
| +59% | +$727K |
|
1608
Cerus
CERS
$572M
| $2.4M | ﹤0.01% |
362,900
+54,600
| +18% | +$313K |
|
1609
Empire State Realty Trust
ESRT
$817M
| $2.39M | ﹤0.01% |
341,400
+44,800
| +15% | +$346K |
|
1610
Malibu Boats
MBUU
$576M
| $2.38M | ﹤0.01% |
45,900
+6,000
| +15% | +$240K |
|
1611
Acadia Realty Trust
AKR
$2.84B
| $2.38M | ﹤0.01% |
183,400
+14,800
| +9% | +$184K |
|
1612
Transocean
RIG
$6.39B
| $2.38M | ﹤0.01% |
1,299,030
+290,400
| +29% | +$451K |
|
1613
Macerich
MAC
$6.99B
| $2.37M | ﹤0.01% |
264,615
+45,415
| +21% | +$352K |
|
1614
City Holding Co
CHCO
$2.08B
| $2.37M | ﹤0.01% |
36,400
+4,800
| +15% | +$304K |
|
1615
Alector
ALEC
$228M
| $2.37M | ﹤0.01% |
+97,000
| New | +$2.68M |
|
1616
Enviri
NVRI
$583M
| $2.37M | ﹤0.01% |
175,200
+21,500
| +14% | +$216K |
|
1617
TriMas Corp
TRS
$1.41B
| $2.37M | ﹤0.01% |
98,800
+11,500
| +13% | +$264K |
|
1618
Enerpac Tool Group
EPAC
$1.91B
| $2.36M | ﹤0.01% |
134,100
+16,400
| +14% | +$277K |
|
1619
Pilgrim's Pride
PPC
$6.57B
| $2.35M | ﹤0.01% |
139,300
+18,300
| +15% | +$357K |
|
1620
Brinker International
EAT
$10.2B
| $2.35M | ﹤0.01% |
98,000
+25,500
| +35% | +$547K |
|
1621
Liberty Latin America Class C
LILAK
$1.67B
| $2.35M | ﹤0.01% |
290,765
+23,364
| +9% | +$199K |
|
|
DHC
1622
Diversified Healthcare Trust
DHC
$2.02B
| $2.35M | ﹤0.01% |
530,700
+69,300
| +15% | +$245K |
|
1623
Upwork
UPWK
$1.08B
| $2.35M | ﹤0.01% |
162,600
+54,000
| +50% | +$567K |
|
|
XHR
1624
Xenia Hotels & Resorts
XHR
$1.73B
| $2.35M | ﹤0.01% |
251,680
+33,200
| +15% | +$309K |
|
|
CVGW
1625
DELISTED
Calavo Growers
CVGW
| $2.35M | ﹤0.01% |
37,300
+4,900
| +15% | +$294K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.